Loading…
Based on limited metadata, this warning letter was issued to Agena Bioscience, Inc., a medical device manufacturer, on March 21, 2024. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The FDA's device regulatory division identified sufficient compliance concerns to warrant formal warning letter action. Additional details would require review of the complete correspondence to specify the particular manufacturing, labeling, or quality system deficiencies cited.